Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
Published November 11, 2026 · Recall initiated: October 20, 2026
Summary
FDA records drug Class II recall D-0165-2027, published November 11, 2026 and initiated October 20, 2026. Recalling firm: Hikma Pharmaceuticals USA INC.; Status: Ongoing; Reported quantity: 29,085 bottles; Lot: Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
What to do
Voluntary: Firm initiated · Letter
Get an email if CIPROFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIPROFLOXACIN
- Manufacturer
- Hikma Pharmaceuticals USA INC.
- Distributor
- US Nationwide
- Lot
- Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACiprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. BoxNovember 11, 2026
- FDATychasis Coats Aloe Liniment (Methyl salicylate 10%), packaged a) 0.5 oz, b) 8 oz (NDC 70211-704-08) c) 33ozNovember 11, 2026
- FDATychasis Coats Aloe Creme (Allantoin 0.5%), packaged in a) 4oz (NDC 70211-703-04), and b)16 oz (NDCNovember 11, 2026
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: LeadingMarch 26, 2025
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, DistributedJanuary 15, 2025
- FDACiprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5August 7, 2024
Questions about this recall
Was Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01 recalled?
Yes. FDA published recall D-0165-2027 on November 11, 2026. Reported hazard: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIPROFLOXACIN.